Log in or Sign up for Free to view tailored content for your specialty!
Hematology/Oncology News
Disability insurance protects against financial demise
Like many sports, such as soccer and basketball, financial independence requires simultaneous offense and defense. One of the most important defensive plays a physician must make is buying disability insurance.
Lung cancer risks persist with e-cigarette use after quitting tobacco smoking
SAN DIEGO — Smokers who used electronic cigarettes after quitting had more risk for lung cancer than those who quit but did not use e-cigarettes, according to a study presented at the American Thoracic Society International Conference.
Log in or Sign up for Free to view tailored content for your specialty!
Quitting smoking after cancer diagnosis may alter prognosis, provide ‘dramatic’ benefits
Individuals with laryngeal cancer who stop smoking in the 2- to 4-week window between diagnosis and their first treatment can significantly improve their response to therapy, survival rates and quality of life.
Oncologist, former comedian: Sharing ‘individuality’ with patients builds connection, trust
Editor’s note: This is the third in a series of five stories from ASCO Voices, a session during ASCO Annual Meeting that focused on the human side of oncology.
Medical oncologist, health policy specialist to receive award for quality care
Ethan Basch, MD, MSc, FASCO, will receive the Joseph Simone Quality Care Award and Lecture at this year’s ASCO Quality Care Symposium, scheduled for Sept. 27-28.
Rosacea, melanoma linked in white patients
Patients with rosacea have an increased risk for malignant melanoma, joint problems, metabolic disease and visual disturbances, according to a study.
VIDEO: ‘More movement’ in nontransplant-eligible multiple myeloma population
CHICAGO — In this video, Sandra Mazzoni, DO, highlights data in nontransplant-eligible patients with multiple myeloma presented at ASCO Annual Meeting.
Abemaciclib regimen extends PFS in advanced breast cancer
CHICAGO — The addition of abemaciclib to fulvestrant extended PFS for patients with advanced breast cancer whose disease progressed on prior cyclin-dependent kinase 4/6 inhibitor therapy, according to data presented at ASCO Annual Meeting.
VIDEO: AI learning may reveal treatment outcome patterns in multiple myeloma
CHICAGO — Sandra Mazzoni, DO, spoke with Healio about a study presented at ASCO Annual Meeting she was part of investigating the use of AI to determine any patterns in how patients with multiple myeloma respond to therapy.
VIDEO: MRD testing a hot topic in multiple myeloma
CHICAGO — In this video, Sandra Mazzoni, DO, discusses the use of minimal residual disease, or MRD, testing in multiple myeloma.
-
Headline News
First US case of clade I mpox reported in California
November 18, 20242 min read -
Headline News
'On the frontlines of public health': Physicians leverage trust against firearm violence
November 19, 20246 min read -
Headline News
Data support early, continued lecanemab dosing for Alzheimer’s
November 19, 20242 min read
-
Headline News
First US case of clade I mpox reported in California
November 18, 20242 min read -
Headline News
'On the frontlines of public health': Physicians leverage trust against firearm violence
November 19, 20246 min read -
Headline News
Data support early, continued lecanemab dosing for Alzheimer’s
November 19, 20242 min read